The mammalian cell fermentation technology market is estimated to be worth US$ 45.9 billion in 2024 and is projected to be valued at US$ 68 billion by 2034. The growing number of biologic drug approvals and clinical trials further contribute to market growth. From 2019 to 2023, the mamman cell fermentation technology market expanded at a CAGR of 4.8% through 2034. The global cell culture incubator market is expected to grow from US$ 3,513.8 million in 2023 to US$ 6,699.93